Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway

Syndecan-4 is a member of the polysaccharide syndecan family and plays a vital role in intervertebral disc development. Several studies have demonstrated the positive relationship between syndecan-4 expression and intervertebral disc degeneration. However, the detailed molecular mechanism by which s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jun, Cheng, Xiaoqiang, Yuan, Chenxi, Qian, Jiale, Wu, Chunshen, Cao, Cheng, Yang, Huilin, Zhou, Feng, Zou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019137/
https://www.ncbi.nlm.nih.gov/pubmed/32071547
http://dx.doi.org/10.7150/ijbs.40189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019137/
https://www.ncbi.nlm.nih.gov/pubmed/32071547
http://dx.doi.org/10.7150/ijbs.40189

Ejemplares similares